英文摘要 |
The continuous advancement of medical technology has brought hope for their cure for many patients, but it has also produced various ethical problems that have not appeared in the past. For instance, the use of various lifesustaining treatments may give a chance to keep alive to critically ill patients, but may also prolong their dying process or may even increase their suffering if they have no hope of healing. Although the Hospice Palliative Care Act enacted in 2000 in Taiwan have enabled terminally ill patients to choose palliative care and to decide not to receive or withdraw from life-sustaining treatments by signing a letter of intent, patients who are not yet in the final stage but may be irreversible, such as patients in a permanent vegetative state, have not been able to free themselves from their predicament through this Act. Hence, the Patient Right to Autonomy Act enacted in 2016 and begins to implement this year, provides a way out for such patients suffering from their disease. In addition to affirming patient's right to know, choice and decision, the Act also stipulates that patient may choose to terminate, withdraw or not receive life-sustaining treatment or artificial nutrition and hydration through advanced decision when the patient is in the five clinical conditions listed in the Act, including permanent vegetative state, Although the Patient Right to Autonomy Act, compared to the Hospice Palliative Care Act, does expand patient autonomy and provide more choices for certain types of critically ill patients other than terminal patients, whether it is able to adequately address the problems encountered by them and their families is still open to question. This paper aims at reviewing the limitations of the Patient Right to Autonomy Act through a reflection on the case of Wang Xiao-Min, a well-known medical vegetative state patient in Taiwan, and proposing some revisions of the Act from the Confucian point of view and reference to other relevant foreign medical cases. |